Exploring Nanotechnology for Myofibroblast-Specific Inhibition of Rho Kinase-MRTF-SRF Pathway
Time: 9:30 am
day: Day Two
Details:
• Exploring the role Rho Kinase-MRTF-SRF pathway in myofibroblast activity and fibrotic lung diseases
• Defining nanotechnology-based myofibroblast inhibition as a novel and promising approach
• Exploring the new possibilities of nanotechnology and the promise it holds for targeted drug delivery in the lungs
